These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23553743)

  • 1. Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events.
    Zeidan AM; Streiff MB; Lau BD; Ahmed SR; Kraus PS; Hobson DB; Carolan H; Lambrianidi C; Horn PB; Shermock KM; Tinoco G; Siddiqui S; Haut ER
    Am J Hematol; 2013 Jul; 88(7):545-9. PubMed ID: 23553743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma.
    Haut ER; Lau BD; Kraenzlin FS; Hobson DB; Kraus PS; Carolan HT; Haider AH; Holzmueller CG; Efron DT; Pronovost PJ; Streiff MB
    Arch Surg; 2012 Oct; 147(10):901-7. PubMed ID: 23070407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic outcomes with appropriate or partial prophylaxis.
    Amin AN; Lin J; Johnson BH; Schulman KL
    Thromb Res; 2010 Jun; 125(6):513-7. PubMed ID: 19931121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based venous thromboembolism prophylaxis is associated with a six-fold decrease in numbers of symptomatic venous thromboembolisms in rehabilitation inpatients.
    Mayer RS; Streiff MB; Hobson DB; Halpert DE; Berenholtz SM
    PM R; 2011 Dec; 3(12):1111-1115.e1. PubMed ID: 22192320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects in Processes of Care for Pharmacologic Prophylaxis Are Common Among Neurosurgery Patients Who Develop In-Hospital Postoperative Venous Thromboembolism.
    Yun R; Sciubba DM; Lewin JJ; Streiff MB; Haut ER; Lau BD; Shermock KM; Kraus PS; Popoola VO; Dalpoas SE
    World Neurosurg; 2020 Feb; 134():e664-e671. PubMed ID: 31698120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a venous thromboembolism prophylaxis program for hospitalized patients.
    Cardoso LF; Krokoscz DV; de Paiva EF; Furtado IS; Mattar J; de Souza E Sá MM; de Lira AC
    Vasc Health Risk Manag; 2016; 12():491-496. PubMed ID: 28003757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a mandated venous thromboembolism clinical order set improves venous thromboembolism core measures.
    Khoury L; Dangodara AA; Lee JA; Lovejoy M; Amin AN
    Hosp Pract (1995); 2014 Dec; 42(5):89-99. PubMed ID: 25485921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients: Implementation and Evaluation of a Caprini Risk Assessment Protocol.
    Hachey KJ; Sterbling H; Choi DS; Pinjic E; Hewes PD; Munoz J; McAneny D; Tripodis Y; Fernando HC; Litle VR
    J Am Coll Surg; 2016 Jun; 222(6):1019-27. PubMed ID: 26775163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the National Inpatient Medication Chart improves venous thromboembolism prophylaxis rates in high-risk medical patients.
    Yates M; Reddy M; Machumpurath B; Phelps G; Hampson SA
    Intern Med J; 2014 Feb; 44(2):190-4. PubMed ID: 24528815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliminating Health Care Disparities With Mandatory Clinical Decision Support: The Venous Thromboembolism (VTE) Example.
    Lau BD; Haider AH; Streiff MB; Lehmann CU; Kraus PS; Hobson DB; Kraenzlin FS; Zeidan AM; Pronovost PJ; Haut ER
    Med Care; 2015 Jan; 53(1):18-24. PubMed ID: 25373403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients.
    Yang LS; Alukaidey S; Croucher K; Dowling D
    Intern Med J; 2018 Sep; 48(9):1056-1063. PubMed ID: 29468795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.
    Prescott LS; Kidin LM; Downs RL; Cleveland DJ; Wilson GL; Munsell MF; DeJesus AY; Cain KE; Ramirez PT; Kroll MH; Levenback CF; Schmeler KM
    Int J Gynecol Cancer; 2015 Jan; 25(1):152-9. PubMed ID: 25365592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism risk and prophylaxis prescription in surgical patients at a tertiary hospital in Eastern Cape Province, South Africa.
    Rocher WD; Page T; Rocher M; Nel D
    S Afr Med J; 2019 Feb; 109(3):178-181. PubMed ID: 30834875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Johns Hopkins Venous Thromboembolism Collaborative: Multidisciplinary team approach to achieve perfect prophylaxis.
    Streiff MB; Lau BD; Hobson DB; Kraus PS; Shermock KM; Shaffer DL; Popoola VO; Aboagye JK; Farrow NA; Horn PJ; Shihab HM; Pronovost PJ; Haut ER
    J Hosp Med; 2016 Dec; 11 Suppl 2():S8-S14. PubMed ID: 27925423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
    Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
    J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study.
    Goldin M; Cohen J; Makhnevich A; Mulvany C; Akerman M; Sinvani L
    J Thromb Thrombolysis; 2018 Apr; 45(3):369-376. PubMed ID: 29330739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.
    Cohen AT; Tapson VF; Bergmann JF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Zayaruzny M; Emery L; Anderson FA;
    Lancet; 2008 Feb; 371(9610):387-94. PubMed ID: 18242412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
    Amin AN; Lin J; Lenhart G; Schulman KL
    Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.